ROTH Research

Scott R. Henry, CFA
Managing Director, Senior Research Analyst &
Head of Pharmaceuticals Research

t: 949-720-7123, e:

Joined ROTH: February 2008
Coverage: Pharmaceuticals, Medical Technology
Education: University of Rhode Island & Cornell University
Experience: Oppenheimer, Thomas Weisel Partners, ABN AMRO, and Leerink Swann & Co.

Drugs Industry No. 3 “Best Brokerage Analyst” Award, Forbes/Zacks 2010
Pharmaceuticals No. 2 Master Stock Picker “Best on the Street” Award, The Wall Street Journal 2010
Pharmaceuticals No. 3 Earnings Estimator Award, FT | StarMine 2011
Pharmaceuticals No. 2 Top Stock Picker Award, Thomson Reuters | Starmine 2014

View expanded biography

Scott R Henry

Transactions // Privacy Policy // Conditions of Use // Initial Margin Disclosure Statement // Business Continuity Disclosure // Best Execution Reports // Contact ROTH // Locations
Annual Notice of Important Policies and Disclosures
Copyright ©2018 ROTH Capital Partners, LLC // Member FINRA/SIPC